Alzheimer's blood test detects brain damage years before symptoms

CATHARINE PADDOCK PHD | January 22, 2019

article image
A blood test for a protein could identify people in the early stages of Alzheimer's disease a decade or more before symptoms, such as a decline in memory and thinking, emerge. This was what an international group of scientists concluded after evaluating the simple test that used blood samples from people with a rare form of Alzheimer's disease that they had inherited.

Spotlight

CellTrak Technologies

People receive exceptional care in their home and community when their providers use CellTrak's software to better manage the delivery of care and the people who deliver it. CellTrak is the clear leader in its category, growing rapidly, and continually bringing new innovations to home health, home hospice, home care, and community care agencies, to health systems and other pre-and post-acute providers, and to payers in the US, Canada, and the UK. With CellTrak, agencies deliver higher quality care, communicate more effectively, improve compliance, reduce costs, and increase productivity.

OTHER ARTICLES

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | February 11, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | April 11, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | March 6, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Spotlight

CellTrak Technologies

People receive exceptional care in their home and community when their providers use CellTrak's software to better manage the delivery of care and the people who deliver it. CellTrak is the clear leader in its category, growing rapidly, and continually bringing new innovations to home health, home hospice, home care, and community care agencies, to health systems and other pre-and post-acute providers, and to payers in the US, Canada, and the UK. With CellTrak, agencies deliver higher quality care, communicate more effectively, improve compliance, reduce costs, and increase productivity.

Events